a16z Capital Management, L.L.C.
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 1540358
MENLO PARK, CA
Position in DNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$665,521
-$236,679 QoQ
Shares Held
108,568
0.0% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026a16z Capital Management, L.L.C. holds $304,679,821 across 8 Biotechnology names. DNA ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
921,099 | $89,576,877 | |
| 2 | NAUT |
Nautilus Biotechnology, Inc.
|
17,653,917 | $68,497,197 | |
| 3 | MAZE |
Maze Therapeutics, Inc.
|
1,702,225 | $50,811,416 | |
| 4 | ERAS |
Erasca, Inc.
|
2,862,500 | $46,315,250 | |
| 5 | DMRA |
Damora Therapeutics, Inc.
|
1,236,157 | $32,016,466 | |
| 6 | CAMP |
Camp4 Therapeutics Corp
|
2,125,339 | $9,372,744 | |
| 7 | AKTS |
Aktis Oncology, Inc.
|
415,000 | $7,424,350 | |
| 8 | DNA |
Ginkgo Bioworks Holdings, Inc.
This page
|
108,568 | $665,521 |
All Filings in DNA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $665,521 | 108,568 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $902,200 | 108,568 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,582,921 | 108,568 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,221,390 | 108,568 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $618,837 | 108,568 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,066,137 | 108,568 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $884,829 | 108,568 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||